WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ('WiMi' or the 'Company'), a leading global Hologram Augmented Reality ('AR') Technology provider, announced that they are researching the use of neural ...

All 63 donor-recipient pairs enrolled and treated according to protocol across multiple clinical centersRandomized, ...

Discover how a robust Quality Engineering strategy became the backbone of a decade-long core banking transformation, ...

Immunis, a clinical-stage biotech company developing a first-in-class multi-active biologic, announced the launch of its new ...

SAT-3247 has now received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations for Duchenne muscular dystrophy ("Duchenne" or "DMD")Fast Track is designed to expedite the development/re ...

Plant-based foods are expanding rapidly, but they pose distinctive challenges for both probiotic delivery and shelf-life stabilization. Unlike dairy, plant ...

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with ...

The Kalecki-Levy profit equation shows how $1.9 trillion US deficits fuel corporate earnings, creating trade-offs for equity ...

Avalyn Pharma Inc. (Nasdaq: AVLN) (Avalyn or the Company), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment ...

The New Jersey Supreme Court recently issued an important decision for nonprofit healthcare providers, federally qualified ...

Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company develop ...

Takeda ( TSE:4502/NYSE:TAK) today presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton (TAK-861), an oral orexin receptor 2 (OX2R)-selective agonist, improved daily ...